Chemoinformaics analysis of 2,6-Phenanthrenediol, 1,5,7-trimethoxy-
| Molecular Weight | 300.31 | nRot | 3 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 16 |
| Exact Molecular Weight | 300.1 | nRing | 3 |
| Solubility: LogS | -4.287 | nHRing | 0 |
| Solubility: LogP | 3.308 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 3 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
| nHA | 5 | APOL | 43.0687 |
| nHD | 2 | BPOL | 21.2593 |
| QED | 0.725 |
| Synth | 2.376 |
| Natural Product Likeliness | 1.355 |
| NR-PPAR-gamma | 0.954 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.008 |
| HIA | 0.013 |
| CACO-2 | -4.959 |
| MDCK | 0.0000313 |
| BBB | 0.022 |
| PPB | 0.886736 |
| VDSS | 0.484 |
| FU | 0.137615 |
| CYP1A2-inh | 0.964 |
| CYP1A2-sub | 0.968 |
| CYP2c19-inh | 0.403 |
| CYP2c19-sub | 0.543 |
| CYP2c9-inh | 0.541 |
| CYP2c9-sub | 0.868 |
| CYP2d6-inh | 0.481 |
| CYP2d6-sub | 0.891 |
| CYP3a4-inh | 0.403 |
| CYP3a4-sub | 0.287 |
| CL | 9.842 |
| T12 | 0.739 |
| hERG | 0.052 |
| Ames | 0.671 |
| ROA | 0.56 |
| SkinSen | 0.94 |
| Carcinogencity | 0.508 |
| EI | 0.937 |
| Respiratory | 0.781 |
| NR-Aromatase | 0.82 |
| Antiviral | Yes |
| Prediction | 0.752381 |